Market News (Page 6) - TendieTensor

Market News Page 6 of 280 • 6,979 articles

Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm

01/09/2026 12:00 PM • A class action lawsuit has been filed against SLM Corporation (Sallie Mae) alleging that the company made materially false and misleading statements regarding its business operations. The complaint claims SLM failed to disclose a significant increase in early-stage delinquencies and overstated the effectiveness of its loss mitigation programs. Investors who purchased SLM securities between July 25, 2025 and August 14, 2025 are eligible to join the case, with a lead plaintiff deadline of February 17, 2026.

SREA - Mentioned as parent company of SoCalGas with no specific positive or negative indicators in the article
SLM - The company is the subject of a securities fraud class action lawsuit alleging material misstatements about business operations, delinquency rates, and loan modification program effectiveness. These allegations of fraud and investor harm create significant negative sentiment.

#class action lawsuit #securities fraud #SLM Corporation #Sallie Mae #loan delinquencies #investor harm #false statements #loss mitigation

Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/09/2026 12:00 PM • A class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) alleging securities fraud. The complaint claims that Stride made misleading statements about its educational products and services while engaging in practices such as inflating enrollment numbers with 'ghost students,' exceeding teacher caseload limits, ignoring compliance requirements, and suppressing whistleblowers. The class period covers October 22, 2024 to October 28, 2025, with a lead plaintiff deadline of January 12, 2026.

LRN - The company is the subject of a securities fraud class action lawsuit alleging systematic misconduct including enrollment fraud, labor law violations, compliance failures, and whistleblower suppression. These serious allegations of deceptive practices and regulatory violations create significant legal and reputational risk for investors.

#class action lawsuit #securities fraud #Stride Inc. #investor harm #misleading statements #ghost students #enrollment inflation #compliance violations #whistleblower suppression

Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm

01/09/2026 12:00 PM • A class action lawsuit has been filed against Klarna Group plc alleging that the company made false and misleading statements in its September 2025 IPO registration statement. The complaint claims Klarna materially understated the risk of increased loss reserves and failed to disclose risks related to its buy-now-pay-later loan portfolio. Investors who purchased Klarna securities during the IPO can join the case with a lead plaintiff deadline of February 20, 2026.

KLAR - The company is the subject of a securities fraud class action lawsuit alleging material misstatements and omissions in its IPO registration statement regarding loss reserve risks and BNPL loan portfolio risks, which directly harms investor confidence and shareholder value.

#class action lawsuit #securities fraud #IPO #loss reserves #buy-now-pay-later #BNPL #investor harm #registration statement

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

Benzinga • Globe Newswire

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

01/09/2026 11:56 AM • Bright Minds Biosciences (NASDAQ: DRUG) successfully closed a public offering of 1.945 million common shares at US$90 per share, raising US$175.05 million in gross proceeds. The company plans to use the net proceeds to fund clinical trials for drug candidates targeting absence seizures, DEE, Prader-Willi Syndrome, and BMB-105, along with R&D and general corporate purposes.

DRUG - The company successfully closed a substantial $175 million public offering, demonstrating strong investor confidence and securing significant capital to advance its clinical pipeline for neurological and psychiatric disorders. The funding provides a solid foundation for expanding drug development programs.

#public offering #capital raise #clinical trials #biotechnology #neurological disorders #drug development

Vanguard Announces Cash Distributions for the Vanguard ETFs

Benzinga • Globe Newswire

Vanguard Announces Cash Distributions for the Vanguard ETFs

01/09/2026 11:46 AM • Vanguard Investments Canada Inc. announced final January 2026 cash distributions for two Canadian-listed ETFs on the Toronto Stock Exchange. The Vanguard FTSE Canadian Capped REIT Index ETF (VRE) will distribute $0.0739 per unit, while the Vanguard FTSE Canadian High Dividend Yield Index ETF (VDY) will distribute $0.1705 per unit. Distributions are payable on January 23, 2026 to unitholders of record on January 16, 2026.

VYM - Monthly distribution of $0.1705 per unit announced, showing continued dividend payments to investors. The relatively higher distribution amount compared to VRE reflects the fund's focus on high-yield dividend stocks.

#cash distributions #ETF #Toronto Stock Exchange #dividend #REIT #high dividend yield

Compass Completes Landmark Anywhere Merger, Stock Soars

Benzinga • Akanksha Bakshi

Compass Completes Landmark Anywhere Merger, Stock Soars

01/09/2026 11:34 AM • Compass Inc. (NYSE:COMP) completed its all-stock merger with Anywhere Real Estate Inc., creating Compass International Holdings valued at approximately $10 billion. The combined company now supports 340,000 real estate professionals across 120+ countries, with Compass shareholders owning 78% and Anywhere shareholders 22%. The merger is expected to deliver over $225 million in annual cost synergies. Compass stock rose 7.79% to $13.21, reaching a new 52-week high. The company also announced a $750 million convertible senior notes offering.

COMP - Stock surged 7.79% to a new 52-week high following successful merger completion. The deal creates significant scale with 340,000 professionals globally, expected $225M+ in annual cost synergies, improved cash flow, and strengthened balance sheet. CEO's optimistic messaging about combining respected brands on modern technology platform reinforces positive outlook.

#merger #real estate #Compass International Holdings #cost synergies #convertible notes #stock offering

Meta’s New AI Glasses See ‘Unprecedented Demand’—What’s Next?

Investing.com • Leo Miller

Meta’s New AI Glasses See ‘Unprecedented Demand’—What’s Next?

01/09/2026 11:33 AM • Meta's new Ray-Ban Display AI glasses are experiencing unprecedented demand with waitlists extending into 2026, but the company has paused international rollout due to extremely limited inventory. While the 6% market share capture in the first quarter is promising for Meta's struggling Reality Labs division, questions remain about whether supply constraints are intentional or due to manufacturing difficulties. The positive demand signals outweighed concerns, with Meta stock rising 0.3% while manufacturing partner EssilorLuxottica surged 5%.

META - Unprecedented demand for new AI glasses product with 6% market share in first quarter provides validation for Reality Labs growth potential and offers hope for offsetting the segment's $18.1B operating loss. However, sentiment is tempered by supply limitations and paused international expansion.

#AI glasses #Meta Ray-Ban Display #unprecedented demand #supply constraints #Reality Labs #hardware innovation #market share

D-Wave’s Year in Review: 2025 Wins Set the Stage for 2026

Investing.com • Nathan Reiff

D-Wave’s Year in Review: 2025 Wins Set the Stage for 2026

01/09/2026 11:31 AM • D-Wave Quantum Inc. (QBTS) tripled in value in 2025 with 232% returns, driven by major partnerships, strong financials with $836M in cash, and technological advances including its Advantage2 system and expansion into gate-model quantum computing. However, the stock is down 30% from October peaks and faces concerns about high valuations (P/S ratio of 1,237), unprofitability, and whether quantum technology can scale to smaller business customers. The company announced a $550M acquisition of Quantum Circuits in early 2026.

QBTS - Mixed outlook: Strong 2025 performance with 232% returns, major partnerships (Carahsoft, Japan Tobacco, Yonsei University), doubled Q3 revenue, and technological breakthroughs (Advantage2, gate-model expansion). However, significant headwinds include 30% decline from October highs, extreme overvaluation (P/S 1,237, P/B 135.6), continued unprofitability, minuscule revenue base, and uncertainty about scalability to broader markets. High short interest (12.47%) reflects investor skepticism.

#quantum computing #D-Wave Quantum #QBTS #quantum supremacy #Advantage2 #gate-model quantum #Quantum Circuits acquisition #valuation concerns #partnerships

Nonwoven Fabrics Market Size to Reach USD 83.78 Billion by 2033, Driven by the Surging Demand for Disposable Hygiene and Medical Products | SNS Insider

GlobeNewswire Inc. • Sns Insider

Nonwoven Fabrics Market Size to Reach USD 83.78 Billion by 2033, Driven by the Surging Demand for Disposable Hygiene and Medical Products | SNS Insider

01/09/2026 11:00 AM • The global nonwoven fabrics market is projected to grow from USD 54.82 billion in 2025 to USD 83.78 billion by 2033, with a CAGR of 5.46%. Growth is driven by increasing demand for disposable hygiene and medical products such as masks, surgical gowns, and diapers. Asia Pacific leads the market with over 40% revenue share and is expected to be the fastest-growing region at 6.30% CAGR.

KMB - Major player in the nonwoven fabrics market with strong positioning in disposable hygiene products (diapers, wipes), which represents 45-50% of global market demand.

#nonwoven fabrics #disposable hygiene products #medical products #market growth #Asia Pacific #spunlaid technology #polypropylene #healthcare demand

Westwood One to Broadcast NFL Wild Card Weekend, Powered by Verizon

GlobeNewswire Inc. • Not Specified

Westwood One to Broadcast NFL Wild Card Weekend, Powered by Verizon

01/09/2026 11:00 AM • Westwood One, the official network audio partner of the NFL, will broadcast all six NFL Wild Card Weekend games across Saturday, January 10, Sunday, January 11, and Monday, January 12, 2026. This marks the 39th consecutive year of exclusive network audio partnership with the NFL. Coverage will be available on approximately 500 radio stations nationwide and multiple digital platforms including westwoodonesports.com, SiriusXM, and NFL+.

DTSTW - The article is a routine conference call announcement with no significant positive or negative business indicators, representing a standard corporate communication
CMLS - Cumulus Media's Westwood One division continues its long-standing exclusive partnership with the NFL for the 39th consecutive year, demonstrating strong retention of a major sports broadcasting contract and extensive distribution across 500+ radio stations and multiple digital platforms, indicating robust business continuity and market reach.

#NFL Wild Card Weekend #Westwood One #network audio partner #live play-by-play coverage #radio broadcast #sports broadcasting

FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm

01/09/2026 11:00 AM • The Schall Law Firm has filed a class action lawsuit against F5, Inc. (NASDAQ: FFIV) for alleged violations of securities laws. The lawsuit claims F5 made false and misleading statements about its security capabilities and ability to meet customer needs, while concealing a security incident that put customers and growth prospects at risk. Investors who purchased F5 securities between October 28, 2024 and October 27, 2025 are encouraged to join the case by February 17, 2026.

FFIV - The company is accused of making false and misleading statements regarding its security capabilities while concealing a material security incident. This represents alleged securities fraud that caused investor losses, resulting in significant reputational and legal risk.

#class action lawsuit #securities fraud #false statements #security incident #shareholder rights #Securities Exchange Act

Military Antenna Market is expected to generate a revenue of USD 6.56 Billion by 2032, Globally, at 5.56% CAGR: Verified Market Research®

GlobeNewswire Inc. • Verified Market Research

Military Antenna Market is expected to generate a revenue of USD 6.56 Billion by 2032, Globally, at 5.56% CAGR: Verified Market Research®

01/09/2026 10:56 AM • The global military antenna market is projected to grow at a CAGR of 5.56% from 2026 to 2032, reaching USD 6.56 billion by 2032 from USD 4.42 billion in 2024. Growth is driven by rising defense budgets, advancements in antenna technologies like phased-array and MIMO systems, and increased demand for tactical communication. However, high costs, regulatory challenges, and cybersecurity threats pose constraints to market expansion.

RTX - Identified as a key player in the military antenna sector with opportunities to capitalize on rising defense budgets and technological advancements in antenna systems.

#military antenna market #defense spending #phased-array antennas #MIMO systems #tactical communication #cybersecurity threats #defense contractors

Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research®

GlobeNewswire Inc. • Verified Market Research

Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research®

01/09/2026 10:53 AM • The global Non-Invasive Prenatal Testing (NIPT) market is projected to grow at a CAGR of 17.01% from 2024 to 2031, reaching USD 9.83 billion from USD 2.8 billion in 2024. Growth is driven by rising demand for early fetal detection, advancements in next-generation sequencing technology, and increased adoption of safer prenatal testing methods. However, high costs, regulatory hurdles, and limited insurance coverage remain significant market restraints, particularly in emerging markets.

NTRA - Listed as a major player in the rapidly growing NIPT market with strong projected growth of 17.01% CAGR through 2031, indicating significant market expansion opportunities.

#Non-Invasive Prenatal Testing #NIPT market #next-generation sequencing #prenatal care #genomic technology #fetal abnormality detection #market growth #healthcare technology

SPAC Merger To Take SL Bio Public Through New Entity In 2026

Benzinga • Priya Nigam

SPAC Merger To Take SL Bio Public Through New Entity In 2026

01/09/2026 10:41 AM • Taiwan-based biotechnology firm SL Bio Ltd. has filed a Form F-4 to merge with Horizon Space Acquisition II Corp. (NASDAQ:HSPT), taking the company public via SPAC at an implied equity valuation of $5.7 billion. The combined entity will operate as SL Science Holding Limited under ticker SLBT, with the public listing expected in early 2026. SL Bio focuses on cellular and gene therapy technologies, immunotherapies for oncology, and exosome-based regenerative technologies.

WMT - Supporting sustainable practices and supply chain optimization
HSPT - As the SPAC acquisition vehicle, HSPT shareholders will benefit from exposure to SL Bio's operations, but the sentiment is neutral as SPACs are primarily vehicles for the transaction rather than operating entities with independent business performance.

#SPAC merger #SL Bio #biotechnology #public listing #gene therapy #immunotherapy #Form F-4 #alternative IPO path

Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034

GlobeNewswire Inc. • Towards Healthcare

Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034

01/09/2026 10:00 AM • The global pulse oximeter market is valued at USD 3.8 billion in 2025 and is expected to grow to USD 6.76 billion by 2034 at a 6.64% CAGR. North America currently dominates the market, while Asia-Pacific is experiencing rapid growth. Key drivers include rising chronic respiratory diseases, remote patient monitoring advancements, and wearable technology innovations. However, the market faces challenges from accuracy issues with darker skin tones and competition from smartwatches.

MDT - Medtronic's investigational Nellcor pulse oximetry technology was incorporated into FDA's Safer Technologies Program for more precise oxygen saturation readings, demonstrating innovation and regulatory advancement.

#pulse oximeter #medical devices #remote patient monitoring #telehealth #respiratory diseases #wearable technology #market growth #COPD #asthma

Wolters Kluwer appoints Maria Montenegro as CEO of Corporate Performance & ESG division

GlobeNewswire Inc. • Na

Wolters Kluwer appoints Maria Montenegro as CEO of Corporate Performance & ESG division

01/09/2026 10:00 AM • Wolters Kluwer announces Maria Montenegro as the new CEO of its Corporate Performance & ESG division, replacing Karen Abramson. Montenegro, who joined the company in 2022 as Chief Strategy & Innovation Officer, brings nearly a decade of McKinsey experience and has been instrumental in driving strategic initiatives including AI partnerships and acquisitions. The division is expected to deliver 2025 organic growth in line with previous guidance.

WTKWY - The appointment of an experienced strategic leader with proven track record in driving growth and transformation, combined with confidence from current and incoming CEOs about the division's market position and growth opportunities, signals positive momentum and organizational strength.

#CEO appointment #Corporate Performance & ESG #Maria Montenegro #strategic leadership #AI partnerships #organic growth

OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit with the Schall Law Firm

01/09/2026 10:00 AM • The Schall Law Firm is seeking lead plaintiffs for a class action lawsuit against Blue Owl Capital Inc. (NYSE: OWL) for securities fraud. The lawsuit alleges the company made false and misleading statements regarding significant pressure on its asset base due to BDC redemptions and undisclosed liquidity issues that would likely result in halted or limited redemptions. Investors who purchased securities between February 6, 2025 and November 16, 2025 are encouraged to participate before February 2, 2026.

OWL - The company is accused of making false and misleading statements to the market, concealing significant pressure on its asset base from BDC redemptions and undisclosed liquidity issues. These allegations of securities fraud and material misstatements resulted in investor losses.

#securities fraud #class action lawsuit #BDC redemptions #liquidity issues #shareholder rights #false statements

Grassroots Carbon Becomes First U.S. Company to Deliver 1.9 Million Tons of Carbon Removals Through Regenerative Ranching

GlobeNewswire Inc. • Grassroots Carbon

Grassroots Carbon Becomes First U.S. Company to Deliver 1.9 Million Tons of Carbon Removals Through Regenerative Ranching

01/09/2026 10:00 AM • Grassroots Carbon announced it has become the first U.S. company to deliver 1.9 million tons of carbon removals through regenerative ranching practices, spanning 2 million acres across 22 states. The company has paid $40 million to ranching partners since 2022 and has over 1.5 million tons of carbon already retired by corporate clients including Nestlé and Microsoft. The milestone demonstrates the scalability of nature-based climate solutions through soil health improvement and rancher profitability.

NSRGY - Nestlé is highlighted as a trusted corporate partner using Grassroots Carbon's soil carbon credits to advance climate commitments, indicating the company is actively investing in verified nature-based climate solutions and meeting sustainability goals.

#carbon removal #regenerative ranching #soil carbon #climate action #grasslands #carbon credits #soil health #nature-based solutions

$12.25+ Bn Airline Route Planning Software Markets, 2020-2025, 2025-2030F, 2035F

GlobeNewswire Inc. • Researchandmarkets.Com

$12.25+ Bn Airline Route Planning Software Markets, 2020-2025, 2025-2030F, 2035F

01/09/2026 09:58 AM • The airline route planning software market is experiencing robust growth, expanding from $8.36 billion in 2025 to a projected $12.27 billion by 2030 with a 7.9% CAGR. Growth is driven by AI-driven predictive tools, real-time data integration, weather intelligence, and increased air travel demand. Key players are leveraging satellite-based tracking and forming strategic partnerships to enhance operational efficiency.

SATS - Mentioned as a top holding but no specific analysis provided
BA - Listed as a prominent industry player in the expanding airline route planning software market, benefiting from growing demand for optimization solutions.

#airline route planning software #market growth #AI-driven predictive tools #real-time data analytics #fuel efficiency #cloud platforms #strategic partnerships #operational efficiency

PRMB INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Primo Brands

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

PRMB INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Primo Brands

01/09/2026 09:55 AM • A federal securities class action has been filed against Primo Brands Corporation for allegedly making false and misleading statements about its merger with BlueTriton Brands. The company claimed the merger would accelerate growth and achieve synergies, but integration failures including supply disruptions, warehouse closures, and technology issues emerged in August 2025. The stock plummeted 36% in two trading sessions after the company slashed guidance and replaced its CEO in November 2025. Investors have until January 12, 2026 to seek lead plaintiff status.

NYT - Mentioned as a top holding but no specific analysis provided
PRMB - The company is accused of securities fraud related to misleading statements about merger benefits. Actual merger integration caused significant operational disruptions, resulting in a 36% stock price drop and CEO replacement. Investors suffered substantial losses due to undisclosed problems.

#securities fraud #class action lawsuit #merger integration #false statements #stock price decline #CEO replacement #guidance reduction

$27.99 Generative Artificial Intelligence (GAI) Media Software Global Markets, 2019-2024, 2024-2029F, 2034F

GlobeNewswire Inc. • Researchandmarkets.Com

$27.99 Generative Artificial Intelligence (GAI) Media Software Global Markets, 2019-2024, 2024-2029F, 2034F

01/09/2026 09:55 AM • The generative AI media software market is experiencing explosive growth, expanding from $6.39 billion in 2024 to $8.61 billion in 2025 with a 34.6% CAGR, projected to reach $27.99 billion by 2029. Growth is driven by increased demand for automated content creation, AI-driven video editing, personalized media experiences, and social media proliferation, with Asia-Pacific emerging as a high-growth region alongside North America's current market leadership.

GWRE - Mentioned as a top holding but no specific analysis provided
MSFT - Listed as a prominent player in the rapidly growing generative AI media software market with strong market expansion projected through 2029.

#generative AI #media software #content creation #video editing #market growth #Asia-Pacific #AI automation #personalization

Investing.com • Timothy Fries

Intel Gets a Sentiment Boost as Trump Support Reframes the Stock’s Risk Profile

01/09/2026 09:54 AM • Intel stock surged on January 9, 2026, following President Trump's enthusiastic endorsement of the chipmaker and CEO Lip-Bu Tan on Truth Social. The stock climbed 2.63% to $42.19 after Trump praised Intel's leadership and highlighted the government's $8.9 billion investment stake, which has grown to over $18 billion in value. Trump also celebrated Intel's launch of sub-2-nanometer CPU processors at CES 2026, marking a significant domestic semiconductor manufacturing achievement.

HCA - Mentioned as a top holding but no specific analysis provided
INTC - Stock surged 2.63% following Trump's enthusiastic endorsement and praise of CEO Lip-Bu Tan. Trump highlighted the government's $8.9 billion investment growing to $18 billion in value and celebrated Intel's technological achievement with sub-2-nanometer processor launch. Melius Research also upgraded the stock to 'Buy' with a $50 price target, indicating positive analyst sentiment despite mixed recovery prospects.

#Intel #Trump endorsement #semiconductor manufacturing #CHIPS Act #sub-2-nanometer processors #stock surge #government investment #domestic chip production

5 Under-the-Radar Consumer Staples Stocks With Pricing Power

Investing.com • Chris Markoch

5 Under-the-Radar Consumer Staples Stocks With Pricing Power

01/09/2026 09:43 AM • Consumer staples stocks underperformed in 2025, but mid-cap names with pricing power and margin protection strategies present opportunities for 2026. Five beaten-down stocks—Hormel Foods, Conagra Brands, Lamb Weston, Post Holdings, and J.M. Smucker—offer solid earnings growth projections, attractive valuations, and dividend yields, with upside potential ranging from 21% to 30%.

SHC - Mentioned as a top holding but no specific analysis provided
HRL - Despite 25% stock decline in 2025 due to tariffs and operational issues, company maintains strong top-line growth and dual pricing power through branded products (SPAM, Applegate, Skippy) and private label manufacturing. Consensus price target of $28.20 implies 28% upside, plus 60-year dividend king status with 5.12% yield.

#consumer staples #pricing power #margin protection #dividend stocks #mid-cap stocks #2026 outlook #value-conscious consumers

Q4 Earnings Preview: Wall Street’s Make-or-Break Moment as Reporting Season Looms

Investing.com • Jesse Cohen

Q4 Earnings Preview: Wall Street’s Make-or-Break Moment as Reporting Season Looms

01/09/2026 09:32 AM • Q4 2025 earnings season begins with major banks leading, as the S&P 500 sits near all-time highs. Analysts expect 8.3% EPS growth and 7.6% revenue growth, with the tech sector leading at 25.7% EPS growth driven by AI demand. Forward P/E ratios are stretched at 21.8, suggesting market valuations could amplify reactions to earnings beats or misses.

AMJB - Major bank kicking off earnings season; investment banking rebounding with focus on fee income and loan growth expected to set positive tone for the season.

#Q4 earnings #earnings season #S&P 500 #AI demand #tech sector #valuation #EPS growth #guidance

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

GlobeNewswire Inc. • Not Specified

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

01/09/2026 09:00 AM • Akari Therapeutics announced progress in 2025 and outlined its path toward clinical transition in 2026. The company established a manufacturing partnership with WuXi Biologics and initiated pre-filing activities, with plans to launch its First-in-Human clinical trial by late 2026/early 2027. The company's lead candidate AKTX-101 is an ADC targeting Trop2 with a novel PH1 spliceosome-modulating payload designed to deliver dual mechanisms of action: direct tumor cytotoxicity and immune activation.

CGEMY - Mentioned as part of Delaporte's professional background, with no direct impact on current business performance
AKTX - Company achieved key milestones in 2025 including manufacturing partnership with WuXi Biologics, initiated CMC activities, and is on track for clinical trial initiation by late 2026/early 2027. Preclinical data shows promising efficacy and safety profile for lead candidate AKTX-101 with potential synergy with checkpoint inhibitors.

#antibody drug conjugates (ADCs) #oncology #PH1 payload #AKTX-101 #clinical trial #spliceosome modulation #immuno-oncology #Trop2 receptor #manufacturing partnership